Posted on Jan 19, 2022
Landmark study: 4th vaccine dose failing against omicron!
2.01K
65
15
19
19
0
Health
Research
Edited 3 y ago
Posted 3 y ago
Responses: 6
8
8
0
Thank you for the medical news share, according to a news report last night, if you get the omicron variant, it helps your immunity MAJ Dale E. Wilson, Ph.D.
(8)
(0)
SGT Mary G.
Perhaps getting one of the variants is the best way to develop some amount of immunity that might result in other variants being less deadly? A friend on the rez (one of the places where vaccines were tested before let loose on the general public) told me yesterday that two of her co-workers who had covid last year, were not back to work yet from getting covid again - both vaccinated and boostered.
(3)
(0)
6
6
0
Israeli study shows 4th shot of COVID-19 vaccine less effective on Omicron
A fourth shot of COVID-19 vaccine boosts antibodies to even higher levels than the third jab but it is not enough to prevent Omicron infections, according to...
Thank you my friend MAJ Dale E. Wilson, Ph.D. for posting that the study conducted by the Sheba Medical Center at Tel Aviv, Israel of medical
Image: volunteer with the women's unit of United Hatzalah emergency service N'amah Yetzhak Abohaikal prepares administer the COVID-19 vaccine to a teen girl at Clalit Health Services in Mevaseret Zion, Tuesday, Jan. 11,
Israeli study shows 4th shot of COVID-19 vaccine less effective on Omicron
https://www.youtube.com/watch?v=p66bbwhtFxE
Israel Study: 4th Vaccine Shows Limited Results with Omicron
Background from {{theyeshivaworld.com/news/headlines-breaking-stories/2052069/israel-study-4th-vaccine-shows-limited-results-with-omicron.html]}
January 18, 2022 1:30 pm
An Israeli hospital on Monday said preliminary research indicates a fourth dose of the coronavirus vaccine provides only limited defense against the omicron variant that is raging around the world.
Sheba Hospital last month began administering a fourth vaccine to more than 270 medical workers — 154 who received a Pfizer-BioNtech vaccine and 120 others who received Moderna’s. All had previously been vaccinated three times with the Pfizer-BioNtech vaccine.
The clinical trial found that both groups showed increases in antibodies “slightly higher” than following the third vaccine last year. But it said the increased antibodies did not prevent the spread of omicron.
“Despite increased antibody levels, the fourth vaccine only offers a partial defense against the virus,” said Dr. Gili Regev-Yochay, director of the hospital’s infection disease unit. “The vaccines, which were more effective against previous variants, offer less protection versus omicron.”
The preliminary results raised questions about Israel’s decision to offer a second booster shot — and fourth overall — to its over-60 population. The government says over 500,000 people have received the second booster in recent weeks.
Dr. Nachman Ash, director of Israel’s Health Ministry, said the research did not mean the fourth vaccine effort was a mistake. “It returns the level of antibodies to what it was at the beginning of the third booster. That has great importance, especially among the older population,” he told Channel 13 TV, elaborating that the higher level of antibodies protects the elderly and at-risk populations from serious illness. “Therefore I call on people to continue getting vaccinated,” he asserted.
But he said the research would be taken into account as authorities debate whether to expand the additional booster campaign to the broader population.
Ash also warned that Israel still hasn’t experienced the worst of the Omicron wave. “We’ll see the number of cases begin to drop in another week but we still have two or three difficult weeks ahead.”
Israel was one of the first countries last year to widely vaccinate its population and last summer became the first to offer a booster shot. The latest booster campaign for older Israelis also is believed to be the first of its kind in the world.
Israel’s aggressive vaccination efforts have not been able to stop an omicron outbreak in recent weeks. The variant has caused record-setting infection levels and sent a growing number of people to the hospital, though the numbers of seriously ill remain below previous waves.
It has also forced large numbers of Israelis into quarantine, straining schools and businesses.
Omicron is already dominant in many countries and can also infect those who have been vaccinated or had previously been infected by prior versions of the virus. Early studies, however, show it is less likely to cause severe illness than the previous delta variant. Vaccination and a booster still offer strong protection from serious illness, hospitalization and death.
On Tuesday, the Israeli government said it was shortening the mandatory quarantine period from seven days to five days in order to help keep the economy running.
“This decision will enable us to continue safeguarding public health on the one hand and to keep the economy going at this time on the other, even though it is difficult, so that we can get through this wave safely,” said Prime Minister Naftali Bennett."
FYI SPC Doug BoltonSPC Paul C.CWO4 Terrence Clark
CPL Ronald Keyes JrCDR (Join to see)SGT (Join to see)
SPC Carlton PhelpsCOL Thomas McGrathPFC Andrew "Tommy" M.PO3 Edward RiddleA1C Mike AllenSPC John BryantMaj Maria AvellanedaSgt Larry IrvineCSM Tony Blair SGT David SchraderSSG Roy Kelly II Maj Bill Smith, Ph.D. SMSgt Lawrence McCarter
Image: volunteer with the women's unit of United Hatzalah emergency service N'amah Yetzhak Abohaikal prepares administer the COVID-19 vaccine to a teen girl at Clalit Health Services in Mevaseret Zion, Tuesday, Jan. 11,
Israeli study shows 4th shot of COVID-19 vaccine less effective on Omicron
https://www.youtube.com/watch?v=p66bbwhtFxE
Israel Study: 4th Vaccine Shows Limited Results with Omicron
Background from {{theyeshivaworld.com/news/headlines-breaking-stories/2052069/israel-study-4th-vaccine-shows-limited-results-with-omicron.html]}
January 18, 2022 1:30 pm
An Israeli hospital on Monday said preliminary research indicates a fourth dose of the coronavirus vaccine provides only limited defense against the omicron variant that is raging around the world.
Sheba Hospital last month began administering a fourth vaccine to more than 270 medical workers — 154 who received a Pfizer-BioNtech vaccine and 120 others who received Moderna’s. All had previously been vaccinated three times with the Pfizer-BioNtech vaccine.
The clinical trial found that both groups showed increases in antibodies “slightly higher” than following the third vaccine last year. But it said the increased antibodies did not prevent the spread of omicron.
“Despite increased antibody levels, the fourth vaccine only offers a partial defense against the virus,” said Dr. Gili Regev-Yochay, director of the hospital’s infection disease unit. “The vaccines, which were more effective against previous variants, offer less protection versus omicron.”
The preliminary results raised questions about Israel’s decision to offer a second booster shot — and fourth overall — to its over-60 population. The government says over 500,000 people have received the second booster in recent weeks.
Dr. Nachman Ash, director of Israel’s Health Ministry, said the research did not mean the fourth vaccine effort was a mistake. “It returns the level of antibodies to what it was at the beginning of the third booster. That has great importance, especially among the older population,” he told Channel 13 TV, elaborating that the higher level of antibodies protects the elderly and at-risk populations from serious illness. “Therefore I call on people to continue getting vaccinated,” he asserted.
But he said the research would be taken into account as authorities debate whether to expand the additional booster campaign to the broader population.
Ash also warned that Israel still hasn’t experienced the worst of the Omicron wave. “We’ll see the number of cases begin to drop in another week but we still have two or three difficult weeks ahead.”
Israel was one of the first countries last year to widely vaccinate its population and last summer became the first to offer a booster shot. The latest booster campaign for older Israelis also is believed to be the first of its kind in the world.
Israel’s aggressive vaccination efforts have not been able to stop an omicron outbreak in recent weeks. The variant has caused record-setting infection levels and sent a growing number of people to the hospital, though the numbers of seriously ill remain below previous waves.
It has also forced large numbers of Israelis into quarantine, straining schools and businesses.
Omicron is already dominant in many countries and can also infect those who have been vaccinated or had previously been infected by prior versions of the virus. Early studies, however, show it is less likely to cause severe illness than the previous delta variant. Vaccination and a booster still offer strong protection from serious illness, hospitalization and death.
On Tuesday, the Israeli government said it was shortening the mandatory quarantine period from seven days to five days in order to help keep the economy running.
“This decision will enable us to continue safeguarding public health on the one hand and to keep the economy going at this time on the other, even though it is difficult, so that we can get through this wave safely,” said Prime Minister Naftali Bennett."
FYI SPC Doug BoltonSPC Paul C.CWO4 Terrence Clark
CPL Ronald Keyes JrCDR (Join to see)SGT (Join to see)
SPC Carlton PhelpsCOL Thomas McGrathPFC Andrew "Tommy" M.PO3 Edward RiddleA1C Mike AllenSPC John BryantMaj Maria AvellanedaSgt Larry IrvineCSM Tony Blair SGT David SchraderSSG Roy Kelly II Maj Bill Smith, Ph.D. SMSgt Lawrence McCarter
(6)
(0)
LTC Stephen F.
What study says about efficacy of fourth Covid-19 vaccine shot
CNN’s Ana Cabrera speaks with Dr. Abdul El-Sayed about new data from an Israeli study on the efficacy of a fourth dose of Covid-19 vaccine while Dr. Paul Off...
Image:
1. Israeli Hospital - Fourth Vaccination doesn't stop spread of Omicron
2. Health Ministry director-general Nachman Ash
3. Sheba Hospital in Tel Aviv study -Fourth COVID vaccine still doesn't stop Omicron
What study says about efficacy of fourth Covid-19 vaccine shot -
https://www.youtube.com/watch?v=Roh1eC85jxg
ABC News Israel study - 4th vaccine shows limited results with omicron
Background from {[//abcnews.go.com/Health/wireStory/israel-study-4th-vaccine-shows-limited-results-omicron-82312196]}
An Israeli hospital says preliminary research indicates a fourth dose of the coronavirus vaccine provides only limited defense against the omicron variant that's raging around the world
By JOSEF FEDERMAN Associated Press
January 17, 2022, 7:36 PM
The Associated Press
N'amah Yetzhak Abohaikal, a volunteer with the women's unit of United Hatzalah emerge...
JERUSALEM -- An Israeli hospital on Monday said preliminary research indicates a fourth dose of the coronavirus vaccine provides only limited defense against the omicron variant that is raging around the world.
Sheba Hospital last month began administering a fourth vaccine to more than 270 medical workers — 154 who received a Pfizer-BioNtech vaccine and 120 others who received Moderna's. All had previously been vaccinated three times with the Pfizer-BioNtech vaccine.
The clinical trial found that both groups showed increases in antibodies “slightly higher” than following the third vaccine last year. But it said the increased antibodies did not prevent the spread of omicron.
“Despite increased antibody levels, the fourth vaccine only offers a partial defense against the virus,” said Dr. Gili Regev-Yochay, director of the hospital's infection disease unit. “The vaccines, which were more effective against previous variants, offer less protection versus omicron."
The preliminary results raised questions about Israel's decision to offer a second booster shot — and fourth overall — to its over-60 population. The government says over 500,000 people have received the second booster in recent weeks.
Dr. Nahman Ash, director of Israel's Health Ministry, said the research did not mean the fourth vaccine effort was a mistake. “It returns the level of antibodies to what it was at the beginning of the third booster. That has great importance, especially among the older population,” he told Channel 13 TV.
But he said the research would be taken into account as authorities debate whether to expand the additional booster campaign to the broader population.
Israel was one of the first countries last year to widely vaccinate its population and last summer became the first to offer a booster shot. The latest booster campaign for older Israelis also is believed to be the first of its kind in the world.
Israel's aggressive vaccination efforts have not been able to stop an omicron outbreak in recent weeks. The variant has caused record-setting infection levels and sent a growing number of people to the hospital, though the numbers of seriously ill remain below previous waves.
It has also forced large numbers of Israelis into quarantine, straining schools and businesses.
Omicron is already dominant in many countries and can also infect those who have been vaccinated or had previously been infected by prior versions of the virus. Early studies, however, show it is less likely to cause severe illness than the previous delta variant. Vaccination and a booster still offer strong protection from serious illness, hospitalization and death.
On Tuesday, the Israeli government said it was shortening the mandatory quarantine period from seven days to five days in order to help keep the economy running.
"This decision will enable us to continue safeguarding public health on the one hand and to keep the economy going at this time on the other, even though it is difficult, so that we can get through this wave safely,” said Prime Minister Naftali Bennett."
FYI PO2 Marco MonsalveSSgt Joseph BaptistMSgt (Join to see)SPC William WilsonCSM Bob Stanek
PVT Mark WhitcombSSG (Join to see)LTC Rick BogdanCPT (Join to see)SPC Maurice Evans]SFC Eric HarmonMAJ Byron OylerMSgt Gloria VanceLTC David StarkSGT Tiffanie G.SFC Kathy PepperSPC Steven DepuyPO3 Myles PostSGT Juan RobledoSSG Ken Potts
1. Israeli Hospital - Fourth Vaccination doesn't stop spread of Omicron
2. Health Ministry director-general Nachman Ash
3. Sheba Hospital in Tel Aviv study -Fourth COVID vaccine still doesn't stop Omicron
What study says about efficacy of fourth Covid-19 vaccine shot -
https://www.youtube.com/watch?v=Roh1eC85jxg
ABC News Israel study - 4th vaccine shows limited results with omicron
Background from {[//abcnews.go.com/Health/wireStory/israel-study-4th-vaccine-shows-limited-results-omicron-82312196]}
An Israeli hospital says preliminary research indicates a fourth dose of the coronavirus vaccine provides only limited defense against the omicron variant that's raging around the world
By JOSEF FEDERMAN Associated Press
January 17, 2022, 7:36 PM
The Associated Press
N'amah Yetzhak Abohaikal, a volunteer with the women's unit of United Hatzalah emerge...
JERUSALEM -- An Israeli hospital on Monday said preliminary research indicates a fourth dose of the coronavirus vaccine provides only limited defense against the omicron variant that is raging around the world.
Sheba Hospital last month began administering a fourth vaccine to more than 270 medical workers — 154 who received a Pfizer-BioNtech vaccine and 120 others who received Moderna's. All had previously been vaccinated three times with the Pfizer-BioNtech vaccine.
The clinical trial found that both groups showed increases in antibodies “slightly higher” than following the third vaccine last year. But it said the increased antibodies did not prevent the spread of omicron.
“Despite increased antibody levels, the fourth vaccine only offers a partial defense against the virus,” said Dr. Gili Regev-Yochay, director of the hospital's infection disease unit. “The vaccines, which were more effective against previous variants, offer less protection versus omicron."
The preliminary results raised questions about Israel's decision to offer a second booster shot — and fourth overall — to its over-60 population. The government says over 500,000 people have received the second booster in recent weeks.
Dr. Nahman Ash, director of Israel's Health Ministry, said the research did not mean the fourth vaccine effort was a mistake. “It returns the level of antibodies to what it was at the beginning of the third booster. That has great importance, especially among the older population,” he told Channel 13 TV.
But he said the research would be taken into account as authorities debate whether to expand the additional booster campaign to the broader population.
Israel was one of the first countries last year to widely vaccinate its population and last summer became the first to offer a booster shot. The latest booster campaign for older Israelis also is believed to be the first of its kind in the world.
Israel's aggressive vaccination efforts have not been able to stop an omicron outbreak in recent weeks. The variant has caused record-setting infection levels and sent a growing number of people to the hospital, though the numbers of seriously ill remain below previous waves.
It has also forced large numbers of Israelis into quarantine, straining schools and businesses.
Omicron is already dominant in many countries and can also infect those who have been vaccinated or had previously been infected by prior versions of the virus. Early studies, however, show it is less likely to cause severe illness than the previous delta variant. Vaccination and a booster still offer strong protection from serious illness, hospitalization and death.
On Tuesday, the Israeli government said it was shortening the mandatory quarantine period from seven days to five days in order to help keep the economy running.
"This decision will enable us to continue safeguarding public health on the one hand and to keep the economy going at this time on the other, even though it is difficult, so that we can get through this wave safely,” said Prime Minister Naftali Bennett."
FYI PO2 Marco MonsalveSSgt Joseph BaptistMSgt (Join to see)SPC William WilsonCSM Bob Stanek
PVT Mark WhitcombSSG (Join to see)LTC Rick BogdanCPT (Join to see)SPC Maurice Evans]SFC Eric HarmonMAJ Byron OylerMSgt Gloria VanceLTC David StarkSGT Tiffanie G.SFC Kathy PepperSPC Steven DepuyPO3 Myles PostSGT Juan RobledoSSG Ken Potts
(2)
(0)
SFC Eric Harmon
The larger question is why are we not doing our own studies? Why is the American government relying on foreign entities to publish all the data regarding the actions of this virus?
(3)
(0)
SPC Steven Depuy
LTC Stephen F. not sure what to say, I have my first 3 Pfizer and everyone around me at work has been getting it and so far not me. Don’t know if it’s luck or the vaccine but so far so good.
(4)
(0)
(2)
(0)
5
5
0
Read This Next
Continue with Facebook 
Continue with Google